🔎 Trials Near Me

Akèy › Gliyòm › North Carolina › Durham

Etid klinik pou Gliyòm nan Durham, NC

12 etid pou Gliyòm ap chèche patisipan nan sit nan ak bò kote Durham (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas

Ap rekriteFaz 2
  • Duke University Medical Center, Durham
12 Months – 39 Years · Tout sèks · Mizajou Sep 21, 2026 · NCT06838676

Targeted Pediatric High-Grade Glioma Therapy

Ap rekriteEtid obsèvasyon
  • Duke University Health System, Durham
12 Months – 39 Years · Tout sèks · Mizajou Sep 8, 2026 · NCT05839379

Study of Olutasidenib and Temozolomide in HGG

Ap rekriteFaz 2
  • Duke University Health System, Durham
Laj 12 a 39 · Tout sèks · Mizajou Sep 1, 2026 · NCT06161974

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

Ap rekriteFaz 3
  • Duke Cancer Institute, Durham
Laj 18 ak plis · Tout sèks · Mizajou Aug 28, 2026 · NCT05303519

ViCToRy: Vorasidenib in Combination With Tumor Specific Peptide Vaccine for Recurrent IDH1 Mutant Lower Grade Gliomas

Ap rekriteFaz 1
  • Duke University Medical Center, Durham
Laj 18 ak plis · Tout sèks · Mizajou Aug 24, 2026 · NCT05609994

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

Ap rekriteFaz 2
  • Duke Cancer Center, Durham
Laj 3 a 39 · Tout sèks · Mizajou Aug 24, 2026 · NCT05096481

Lerapolturev (PVSRIPO) in GBM

Ap rekriteFaz 2
  • Duke University Medical Center, Durham
Laj 18 ak plis · Tout sèks · Mizajou Jul 20, 2026 · NCT06177964

Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion

Ap rekriteFaz 1 bonèVolontè an sante akeyi
  • Duke University Health System, Durham
Laj 1 a 21 · Tout sèks · Mizajou Jun 29, 2026 · NCT06333899

Phase 1 Trial of D2C7-IT in Combination With 2141-V11 for Recurrent Malignant Glioma

Ap rekriteFaz 1
  • Duke University Medical Center, Durham
Laj 18 ak plis · Tout sèks · Mizajou Jun 4, 2026 · NCT04547777

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

Ap rekriteFaz 2
  • Duke University Health System, Durham
12 Months – 39 Years · Tout sèks · Mizajou May 29, 2026 · NCT05843253

Open-Label Study to Evaluate the Safety, Tolerability and Efficacy of the Oncolytic HSV1 MVR-C5252

Ap rekriteFaz 1
  • Duke University, Durham
Laj 18 ak plis · Tout sèks · Mizajou Apr 15, 2026 · NCT06126744

A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion

Ap rekriteFaz 1 bonè
  • Duke University Health System, Durham
Jiska laj 21 · Tout sèks · Mizajou Mar 18, 2026 · NCT04655404

Etid Gliyòm nan lòt vil

Lòt etid nan Durham

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.